Peter Kies
CIK: 0001259780
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
INOVIO PHARMACEUTICALS, INC.
Discretionary Trading P&L
Holdings
Transaction History (22 total)
- May 20, 2026INO
INOVIO PHARMACEUTICALS, INC.
Exercise(M)Direct8.7K shares- - May 20, 2026INO
INOVIO PHARMACEUTICALS, INC.
Tax Payment(F)Direct4.7K shares at avg. $1.23$6K - May 20, 2026INO
INOVIO PHARMACEUTICALS, INC.
Award(A)DirectRestricted Stock Unit
32.5K shares- - May 20, 2026INO
INOVIO PHARMACEUTICALS, INC.
Award(A)DirectCommon Stock Option
39.8K shares- - May 15, 2026INO
INOVIO PHARMACEUTICALS, INC.
Exercise(M)Direct4.8K shares- - May 15, 2026INO
INOVIO PHARMACEUTICALS, INC.
Tax Payment(F)Direct2.6K shares at avg. $1.30$3K - Mar 4, 2026INO
INOVIO PHARMACEUTICALS, INC.
Award(A)DirectCommon Stock Option
31.2K shares- - Mar 4, 2026INO
INOVIO PHARMACEUTICALS, INC.
Award(A)DirectRestricted Stock Unit
25.5K shares- - Feb 26, 2026INO
INOVIO PHARMACEUTICALS, INC.
Tax Payment(F)Direct3K shares at avg. $1.79$5K - Feb 26, 2026INO
INOVIO PHARMACEUTICALS, INC.
Exercise(M)Direct5K shares- - Feb 26, 2026INO
INOVIO PHARMACEUTICALS, INC.
Exercise(M)Direct10.6K shares- - Feb 26, 2026INO
INOVIO PHARMACEUTICALS, INC.
Tax Payment(F)Direct6.3K shares at avg. $1.79$11K - May 20, 2025INO
INOVIO PHARMACEUTICALS, INC.
Award(A)DirectRestricted Stock Unit
26.1K shares- - May 20, 2025INO
INOVIO PHARMACEUTICALS, INC.
Award(A)DirectCommon Stock Option
32K shares- - May 15, 2025INO
INOVIO PHARMACEUTICALS, INC.
Exercise(M)Direct4.8K shares- - May 15, 2025INO
INOVIO PHARMACEUTICALS, INC.
Tax Payment(F)Direct2.6K shares at avg. $1.95$5K - Feb 27, 2025INO
INOVIO PHARMACEUTICALS, INC.
Award(A)DirectRestricted Stock Unit
31.9K shares- - Feb 27, 2025INO
INOVIO PHARMACEUTICALS, INC.
Award(A)DirectCommon Stock Option
39.1K shares- - Feb 26, 2025INO
INOVIO PHARMACEUTICALS, INC.
Exercise(M)Direct5K shares- - Feb 26, 2025INO
INOVIO PHARMACEUTICALS, INC.
Tax Payment(F)Direct2.4K shares at avg. $1.98$5K - Feb 26, 2025INO
INOVIO PHARMACEUTICALS, INC.
Exercise(M)Direct4K shares- - Feb 26, 2025INO
INOVIO PHARMACEUTICALS, INC.
Tax Payment(F)Direct3K shares at avg. $1.98$6K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 20, 2026 | INO INOVIO PHARMACEUTICALS, INC. | Exercise(M) | 8,700 | - | $0 | Direct |
| May 20, 2026 | INO INOVIO PHARMACEUTICALS, INC. | Tax Payment(F) | 4,688 | $1.23 | $5,766 | Direct |
| May 20, 2026 | INO INOVIO PHARMACEUTICALS, INC. | Award(A) Restricted Stock Unit | 32,480 | - | - | Direct |
| May 20, 2026 | INO INOVIO PHARMACEUTICALS, INC. | Award(A) Common Stock Option | 39,760 | - | - | Direct |
| May 15, 2026 | INO INOVIO PHARMACEUTICALS, INC. | Exercise(M) | 4,771 | - | $0 | Direct |
| May 15, 2026 | INO INOVIO PHARMACEUTICALS, INC. | Tax Payment(F) | 2,571 | $1.30 | $3,342 | Direct |
| Mar 4, 2026 | INO INOVIO PHARMACEUTICALS, INC. | Award(A) Common Stock Option | 31,240 | - | - | Direct |
| Mar 4, 2026 | INO INOVIO PHARMACEUTICALS, INC. | Award(A) Restricted Stock Unit | 25,520 | - | - | Direct |
| Feb 26, 2026 | INO INOVIO PHARMACEUTICALS, INC. | Tax Payment(F) | 2,965 | $1.79 | $5,307 | Direct |
| Feb 26, 2026 | INO INOVIO PHARMACEUTICALS, INC. | Exercise(M) | 5,010 | - | $0 | Direct |
| Feb 26, 2026 | INO INOVIO PHARMACEUTICALS, INC. | Exercise(M) | 10,634 | - | $0 | Direct |
| Feb 26, 2026 | INO INOVIO PHARMACEUTICALS, INC. | Tax Payment(F) | 6,294 | $1.79 | $11,266 | Direct |
| May 20, 2025 | INO INOVIO PHARMACEUTICALS, INC. | Award(A) Restricted Stock Unit | 26,100 | - | - | Direct |
| May 20, 2025 | INO INOVIO PHARMACEUTICALS, INC. | Award(A) Common Stock Option | 31,950 | - | - | Direct |
| May 15, 2025 | INO INOVIO PHARMACEUTICALS, INC. | Exercise(M) | 4,771 | - | - | Direct |
| May 15, 2025 | INO INOVIO PHARMACEUTICALS, INC. | Tax Payment(F) | 2,566 | $1.95 | $5,004 | Direct |
| Feb 27, 2025 | INO INOVIO PHARMACEUTICALS, INC. | Award(A) Restricted Stock Unit | 31,900 | - | - | Direct |
| Feb 27, 2025 | INO INOVIO PHARMACEUTICALS, INC. | Award(A) Common Stock Option | 39,050 | - | - | Direct |
| Feb 26, 2025 | INO INOVIO PHARMACEUTICALS, INC. | Exercise(M) | 5,010 | - | - | Direct |
| Feb 26, 2025 | INO INOVIO PHARMACEUTICALS, INC. | Tax Payment(F) | 2,362 | $1.98 | $4,677 | Direct |
| Feb 26, 2025 | INO INOVIO PHARMACEUTICALS, INC. | Exercise(M) | 3,997 | - | - | Direct |
| Feb 26, 2025 | INO INOVIO PHARMACEUTICALS, INC. | Tax Payment(F) | 2,960 | $1.98 | $5,861 | Direct |
1-22 of 22 transactions
About KIES PETER
KIES PETER (SEC CIK 0001259780) files insider reports with the SEC as CFO of INOVIO PHARMACEUTICALS, INC. (INO).
Signal8 holds 7 ownership filings by KIES PETER, all Form 4s, filed between Feb 28, 2025 and May 21, 2026. Those filings report 22 transactions, from Feb 26, 2025 to May 20, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on KIES PETER's filings is in SAN DIEGO, CA.
Recent filings by KIES PETER
- May 20, 2026: Option exercise of INO shares (Form 4, code M).
- May 20, 2026: Tax withholding of INO shares (Form 4, code F).
- May 20, 2026: Grants or awards of INO derivative securities (2 lines, Form 4, code A).
- May 15, 2026: Option exercise of INO shares (Form 4, code M).
- May 15, 2026: Tax withholding of INO shares (Form 4, code F).
Other insiders filing for INOVIO PHARMACEUTICALS, INC. (INO)
- YARNO WENDY L, Director
- Shepard Jay, Director
- Miller Ann Calby, Director
- Weiner David B., Director
- Zoth Lota S., Director
- DANSEY ROGER D, Director